Elevated circulating tumor cells reflect high proliferation and genomic complexity in multiple myeloma
Abstract Circulating tumor cells (CTCs) have emerged as a key prognostic factor in newly diagnosed multiple myeloma (NDMM). However, it remains unclear if high CTC counts represent a mere surrogate of tumor burden or might reflect a distinct genomic or transcriptomic entity. In this study, we charac...
| Published in: | HemaSphere |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-09-01
|
| Online Access: | https://doi.org/10.1002/hem3.70218 |
